With the wide application of whole exome and whole genome sequencing in clinical diagnoses, increasing numbers of PP2A subunit pathogenic variants have been identified in NDD patients [7,8,9,10,11]. This evidence concerns the gene PTPA and Neurodevelopmental delay.